Medical aids are cost-effective, says Sweden's SLF (Swedish Association of Suppliers of Medical Devices)
This article was originally published in Clinica
The pricing of medical aids, which are classified together with medical devices as a single group by the Swedish government, is misleading to politicians, claims Anders Hultman, managing director of the Swedish Association of Suppliers of Medical Devices (SLF). His claim follows a study undertaken by Gunilla-Hedstrom at the University of Goteborg, which confirmed that medical aids are a decisive factor in the rehabilitation of stroke patients.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.